Condition: Hypertension · Essential (Primary) Hypertension · Sponsor: Beijing Anzhen Hospital
Yufeng Ningxin, a traditional Chinese medicine, has demonstrated potential antihypertensive effects in animal studies and small clinical trials, but has not yet been rigorously evaluated in large randomized clinical trials. Here, the investigators conducted a double-blind, randomized controlled trial to assess the efficacy and safety of Yufeng Ningxin tablets in patients with hypertension.
This description comes directly from the study's public registry record.
Ruixue Yang, MD · +86-10-81992130 · yangruixue2020@163.com
Always discuss trial participation with your own doctor first.
| Beijing Anzhen Hospital | Beijing, China | Recruiting |
| Chinese PLA General Hospital | Beijing, China | Recruiting |
| Fuwai Hospital, Chinese Academy of Medical Sciences | Beijing, China | Not Yet Recruiting |
| Peking University First Hospital | Beijing, China | Not Yet Recruiting |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Dalian Medical University | Dalian, China | Recruiting |
| Inner Mongolia People's Hospital | Hohhot, China | Not Yet Recruiting |
| Longyan First Hospital | Longyan, China | Not Yet Recruiting |
| Luohe Central Hospital | Luohe, China | Recruiting |
| The Second Affiliated Hospital of Nanchang University | Nanchang, China | Recruiting |
| Jiangsu Province Hospital | Nanjing, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Shantou University Medical College | Shantou, China | Not Yet Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07607275